Thailand has reported a sharp rise in Covid-19 infections, with more than 28,000 new cases recorded over just two days, according to the Department of Disease Control (DDC), The Nation reports.

The DDC announced via its Digital Disease Surveillance (DDS) system that, as of June 2 2025, 10,192 new Covid-19 cases had been confirmed. This followed a previous surge of 18,102 new infections recorded on June 1, bringing the total for the two-day period to 28,294.

Of the newly reported cases, 9,304 were treated as outpatients, while 888 individuals required hospital admission due to the severity of their symptoms. One additional death was also recorded.

As of May 27 2025, The Nation reports, the cumulative number of Covid-19 cases this year stands at 323,301, with 69 fatalities.

Dr Taweesin Visanuyothin, Director-General of the Department of Medical Services, was quoted as saying the recent rise in infections to seasonal and social factors. “The increasing number of cases is likely due to the early arrival of the rainy season and the opening of schools,” he explained.

He noted that the majority of deaths in 2025 have occurred within the so-called “608 group” – elderly individuals and those with underlying health conditions  –  particularly in urban centres and popular tourist destinations such as Bangkok (22 deaths), Chonburi (8), Chanthaburi (7) and Chiang Mai (3). Despite the uptick in cases, the mortality rate remains low at 0.106 per 100,000 people. “This suggests that the disease is not becoming more severe,” he said.

Meanwhile Dr Suthat Chottanapund, Deputy Director-General of the DDC, explained that the surge aligns with expected seasonal trends. “As schools reopen and the rainy season sets in, cases of upper respiratory infections tend to rise, particularly among students, where close contact can easily spread the virus.”

The DDC continues to urge the public to observe basic preventive measures including mask wearing, frequent hand washing, and avoiding crowded spaces particularly to protect older adults. Vaccination against seasonal influenza is also advised to reduce the risk of co-infection.

The Nation also reports a Dr Sakan Bunnag, Deputy Director-General of the Department of Medical Services noting that distinguishing between mild cases of flu, common colds, and Covid-19 can be challenging. He advised medical attention for patients experiencing worsening symptoms, including high fever (above 38.5°C), shortness of breath, fatigue, or blood oxygen levels below 95%. Vulnerable groups include elderly people, individuals with chronic illnesses, children under one year of age and pregnant women.

For severe cases or those in high-risk groups, the primary treatments in Thailand remain Remdesivir and Paxlovid the publication says, and these drugs are still readily available directly from pharmaceutical suppliers. Meanwhile, the Government Pharmaceutical Organisation continues to manufacture Molnupiravir for use in moderate cases without lung complications.

Public health officials in Thailand continue to monitor the situation closely and have urged the public to remain vigilant, but calm, as the nation navigates this seasonal wave of infections.